Efficacy of berberine in patients with type 2 diabetes mellitus - PubMed (original) (raw)
Randomized Controlled Trial
Efficacy of berberine in patients with type 2 diabetes mellitus
Jun Yin et al. Metabolism. 2008 May.
Abstract
Berberine has been shown to regulate glucose and lipid metabolism in vitro and in vivo. This pilot study was to determine the efficacy and safety of berberine in the treatment of type 2 diabetes mellitus patients. In study A, 36 adults with newly diagnosed type 2 diabetes mellitus were randomly assigned to treatment with berberine or metformin (0.5 g 3 times a day) in a 3-month trial. The hypoglycemic effect of berberine was similar to that of metformin. Significant decreases in hemoglobin A1c (from 9.5%+/-0.5% to 7.5%+/-0.4%, P<.01), fasting blood glucose (from 10.6+/-0.9 mmol/L to 6.9+/-0.5 mmol/L, P<.01), postprandial blood glucose (from 19.8+/-1.7 to 11.1+/-0.9 mmol/L, P<.01), and plasma triglycerides (from 1.13+/-0.13 to 0.89+/-0.03 mmol/L, P<.05) were observed in the berberine group. In study B, 48 adults with poorly controlled type 2 diabetes mellitus were treated supplemented with berberine in a 3-month trial. Berberine acted by lowering fasting blood glucose and postprandial blood glucose from 1 week to the end of the trial. Hemoglobin A1c decreased from 8.1%+/-0.2% to 7.3%+/-0.3% (P<.001). Fasting plasma insulin and homeostasis model assessment of insulin resistance index were reduced by 28.1% and 44.7% (P<.001), respectively. Total cholesterol and low-density lipoprotein cholesterol were decreased significantly as well. During the trial, 20 (34.5%) patients experienced transient gastrointestinal adverse effects. Functional liver or kidney damages were not observed for all patients. In conclusion, this pilot study indicates that berberine is a potent oral hypoglycemic agent with beneficial effects on lipid metabolism.
Figures
Fig. 1
Both berberine and metformin decreased FBG and PBG of type 2 diabetic patients significantly from week 1 to week 13. A, means ± SEM of 15 patients treated with berberine alone. B, means ± SEM of 16 patients treated with metformin alone. C, means ± SEM of 43 patients with combination-therapy including berberine.
Similar articles
- Mealtime 50/50 basal + prandial insulin analogue mixture with a basal insulin analogue, both plus metformin, in the achievement of target HbA1c and pre- and postprandial blood glucose levels in patients with type 2 diabetes: a multinational, 24-week, randomized, open-label, parallel-group comparison.
Robbins DC, Beisswenger PJ, Ceriello A, Goldberg RB, Moses RG, Pagkalos EM, Milicevic Z, Jones CA, Sarwat S, Tan MH. Robbins DC, et al. Clin Ther. 2007 Nov;29(11):2349-64. doi: 10.1016/j.clinthera.2007.11.016. Clin Ther. 2007. PMID: 18158076 Clinical Trial. - The effect of a thiazolidinedione drug, troglitazone, on glycemia in patients with type 2 diabetes mellitus poorly controlled with sulfonylurea and metformin. A multicenter, randomized, double-blind, placebo-controlled trial.
Yale JF, Valiquett TR, Ghazzi MN, Owens-Grillo JK, Whitcomb RW, Foyt HL. Yale JF, et al. Ann Intern Med. 2001 May 1;134(9 Pt 1):737-45. doi: 10.7326/0003-4819-134-9_part_1-200105010-00010. Ann Intern Med. 2001. PMID: 11329231 Clinical Trial. - Efficacy and safety of HIMABERB® Berberine on glycemic control in patients with prediabetes: double-blind, placebo-controlled, and randomized pilot trial.
Panigrahi A, Mohanty S. Panigrahi A, et al. BMC Endocr Disord. 2023 Sep 7;23(1):190. doi: 10.1186/s12902-023-01442-y. BMC Endocr Disord. 2023. PMID: 37679692 Free PMC article. Clinical Trial. - The effect of metformin on blood pressure, plasma cholesterol and triglycerides in type 2 diabetes mellitus: a systematic review.
Wulffelé MG, Kooy A, de Zeeuw D, Stehouwer CD, Gansevoort RT. Wulffelé MG, et al. J Intern Med. 2004 Jul;256(1):1-14. doi: 10.1111/j.1365-2796.2004.01328.x. J Intern Med. 2004. PMID: 15189360 Review. - Addressing the preventive and therapeutic perspective of berberine against diabetes.
Shrivastava S, Sharma A, Saxena N, Bhamra R, Kumar S. Shrivastava S, et al. Heliyon. 2023 Nov 3;9(11):e21233. doi: 10.1016/j.heliyon.2023.e21233. eCollection 2023 Nov. Heliyon. 2023. PMID: 38027723 Free PMC article. Review.
Cited by
- Causal relationship between fertility nutrients supplementation and PCOS risk: a Mendelian randomization study.
Shao F, Xu S, Zhao H, Zhang F, Wang X, Wang H. Shao F, et al. Front Endocrinol (Lausanne). 2024 Sep 24;15:1420004. doi: 10.3389/fendo.2024.1420004. eCollection 2024. Front Endocrinol (Lausanne). 2024. PMID: 39381438 Free PMC article. - Mechanisms of Berberine in anti-pancreatic ductal adenocarcinoma revealed by integrated multi-omics profiling.
Yang J, Xu T, Wang H, Wang L, Cheng Y. Yang J, et al. Sci Rep. 2024 Oct 2;14(1):22929. doi: 10.1038/s41598-024-74943-y. Sci Rep. 2024. PMID: 39358545 Free PMC article. - Inflammatory markers and noncoding-RNAs responses to low and high compressions of HIIT with or without berberine supplementation in middle-aged men with prediabetes.
Nikseresht M, Dabidi Roshan V, Nasiri K. Nikseresht M, et al. Physiol Rep. 2024 Aug;12(15):e16146. doi: 10.14814/phy2.16146. Physiol Rep. 2024. PMID: 39107107 Free PMC article. Clinical Trial. - Comparative Effects of Gymnema sylvestre and Berberine on Adipokines, Body Composition, and Metabolic Parameters in Obese Patients: A Randomized Study.
Bandala C, Carro-Rodríguez J, Cárdenas-Rodríguez N, Peña-Montero I, Gómez-López M, Hernández-Roldán AP, Huerta-Cruz JC, Muñoz-González F, Ignacio-Mejía I, Domínguez B, Lara-Padilla E. Bandala C, et al. Nutrients. 2024 Jul 16;16(14):2284. doi: 10.3390/nu16142284. Nutrients. 2024. PMID: 39064727 Free PMC article. Clinical Trial. - Chemical fingerprinting, antimicrobial, antioxidant, anti-inflammatory, and anticancer potential of greenly synthesized silver nanoparticles from pistachio (Pistacia vera) nuts and senna (Cassia angustifolia Vahl.) leaves.
Irshad S, Iftikhar S, Riaz M, Mahmood A, Mushtaq A, Saleem Y, Shamim R, Akter QS. Irshad S, et al. Food Sci Nutr. 2024 Apr 30;12(7):4989-5006. doi: 10.1002/fsn3.4148. eCollection 2024 Jul. Food Sci Nutr. 2024. PMID: 39055186 Free PMC article.
References
- Jayaprakasam B, Olson LK, Schutzki RE, et al. Amelioration of obesity and glucose intolerance in high-fat-fed C57BL/6 mice by anthocyanins and ursolic acid in Cornelian cherry (Cornus mas) J Agric Food Chem. 2006;54:243–8. - PubMed
- Matsui T, Ueda T, Oki T, et al. alpha-Glucosidase inhibitory action of natural acylated anthocyanins. 2. alpha-Glucosidase inhibition by isolated acylated anthocyanins. J Agric Food Chem. 2001;49:1952–6. - PubMed
- Yin J, Hu R, Chen M, et al. Effects of berberine on glucose metabolism in vitro. Metabolism. 2002;51:1439–43. - PubMed
- Yin J, Chen M, Tang J, et al. Effects of berberine on glucose and lipid metabolism in animal experiment. Chinese Journal of Diabetes. 2004;12:215–8.
- Lee YS, Kim WS, Kim KH, et al. Berberine, a natural plant product, activates AMP-activated protein kinase with beneficial metabolic effects in diabetic and insulin-resistant states. Diabetes. 2006;55:2256–64. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- P50 AT002776/AT/NCCIH NIH HHS/United States
- P50 AT002776-020002/AT/NCCIH NIH HHS/United States
- R56 DK068036/DK/NIDDK NIH HHS/United States
- P50 AT02776-020002/AT/NCCIH NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical